According to filings with the U.S. Securities and Exchange Commission, Seranova Bio is raising up to $9,999,995.00 in new funding. Sources indicate that as part of senior management President, Aaron Ring played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Seranova Bio
Seranova is an early-stage company poised to create the next generation of therapeutics. Our proprietary REAP technology enables the dissection of the immune interactions that drive health and disease, while our serological atlas and analytics platform will offer an unprecedented level of insight to help us achieve our mission. Founded in 2020 by Yale professor and serial academic entrepreneur Aaron Ring, Seranova is headquartered in South San Francisco and funded by Foresite Capital Management.

To learn more about Seranova Bio, visit http://www.seranovabio.com/

Contact:
Aaron Ring, President
509-939-4681
https://www.linkedin.com/in/aaron-ring-b34b4869/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.